Day One seeks $150M public offering to fund efforts past NDA filing

Day One Biopharmaceuticals will offer up more than 11.5 million shares to nab $150 million in gross proceeds after the biotech last month started a rolling submission for its pediatric brain cancer drug, which had a fresh data drop at last weekend’s ASCO.

The Brisbane, CA-based…

Advertisement — Advertise with Biotech Networks